185 related articles for article (PubMed ID: 32502498)
21. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
22. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
[TBL] [Abstract][Full Text] [Related]
23. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone.
Gamberi G; Benassi MS; Ragazzini P; Pazzaglia L; Ponticelli F; Ferrari C; Balladelli A; Mercuri M; Gigli M; Bertoni F; Picci P
Ann Oncol; 2004 Mar; 15(3):498-503. PubMed ID: 14998856
[TBL] [Abstract][Full Text] [Related]
24. [Giant-cell tumor of bone in 2022].
Larousserie F; Audard V; Burns R; de Pinieux G
Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.
Atkins GJ; Bouralexis S; Haynes DR; Graves SE; Geary SM; Evdokiou A; Zannettino AC; Hay S; Findlay DM
Bone; 2001 Apr; 28(4):370-7. PubMed ID: 11336917
[TBL] [Abstract][Full Text] [Related]
26. ZNF687 mutations are frequently found in pagetic patients from South Italy: implication in the pathogenesis of Paget's disease of bone.
Divisato G; Scotto di Carlo F; Petrillo N; Esposito T; Gianfrancesco F
Clin Genet; 2018 Jun; 93(6):1240-1244. PubMed ID: 29493781
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics.
Presneau N; Baumhoer D; Behjati S; Pillay N; Tarpey P; Campbell PJ; Jundt G; Hamoudi R; Wedge DC; Loo PV; Hassan AB; Khatri B; Ye H; Tirabosco R; Amary MF; Flanagan AM
J Pathol Clin Res; 2015 Apr; 1(2):113-23. PubMed ID: 27499898
[TBL] [Abstract][Full Text] [Related]
28. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
30. Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone.
Zheng MH; Siu P; Papadimitriou JM; Wood DJ; Murch AR
Pathology; 1999 Nov; 31(4):373-8. PubMed ID: 10643009
[TBL] [Abstract][Full Text] [Related]
31. Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.
Wei Z; Li S; Tao X; Zhu G; Sun Z; Wei Z; Jiao Q; Zhang H; Chen L; Li B; Zhang Z; Yue H
J Bone Miner Res; 2021 Jun; 36(6):1088-1103. PubMed ID: 33599011
[TBL] [Abstract][Full Text] [Related]
32. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
[TBL] [Abstract][Full Text] [Related]
33. Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.
Al-Ibraheemi A; Inwards CY; Zreik RT; Wenger DE; Jenkins SM; Carter JM; Boland JM; Rose PS; Jin L; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2016 Dec; 40(12):1702-1712. PubMed ID: 27526293
[TBL] [Abstract][Full Text] [Related]
34. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
37. The nature of giant cell tumor of bone.
Wülling M; Engels C; Jesse N; Werner M; Delling G; Kaiser E
J Cancer Res Clin Oncol; 2001 Aug; 127(8):467-74. PubMed ID: 11501745
[TBL] [Abstract][Full Text] [Related]
38. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
39. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V
Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511
[TBL] [Abstract][Full Text] [Related]
40. Giant cell tumour of bone: morphological, biological and histogenetical aspects.
Werner M
Int Orthop; 2006 Dec; 30(6):484-9. PubMed ID: 17013643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
